Comments
Loading...

Cartesian Therapeutics

RNACNASDAQ
Logo brought to you by Benzinga Data
$19.02
-0.000500.00%
Pre-Market: Dec 20, 4:30 PM EDT

Cartesian Therapeutics (NASDAQ:RNAC) Stock Quotes, Forecast and News Summary

Cartesian Therapeutics Stock (NASDAQ: RNAC) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 131.84K
Day Range- - -
52 Wk Range11.67 - 41.87
Market Cap$483.38M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
48
Short Interest
11.47%
Days to Cover18.95

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RNAC
KALV

FAQ

Q

How do I buy Cartesian Therapeutics (RNAC) stock?

A

You can purchase shares of Cartesian Therapeutics (NASDAQ:RNAC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cartesian Therapeutics (RNAC) competitors?

Q

What is the forecast, or price target, for Cartesian Therapeutics (RNAC) stock?

A

Cartesian Therapeutics has a consensus price target of $41.67.

Q

What is the current price for Cartesian Therapeutics (RNAC)?

A

The stock price for Cartesian Therapeutics (NASDAQ: RNAC) is $19.0195 last updated December 20, 2024 at 4:30 PM EST.

Q

Does Cartesian Therapeutics (RNAC) pay a dividend?

A

There are no upcoming dividends for Cartesian Therapeutics.

Q

When is Cartesian Therapeutics (NASDAQ:RNAC) reporting earnings?

A

Cartesian Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.

Q

Is Cartesian Therapeutics (RNAC) going to split?

A

There is no upcoming split for Cartesian Therapeutics.

Q

What sector and industry does Cartesian Therapeutics (RNAC) operate in?

A

Cartesian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch